Sign Up Today and Learn More About AlgoTherapeutix Stock
Invest in or calculate the value of your shares in AlgoTherapeutix or other pre-IPO companies through EquityZen's platform.
AlgoTherapeutix Stock (ALGT)
AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
About AlgoTherapeutix Stock
Founded
2018
Industries
Messaging and Telecommunications, Content and Publishing, Sports
AlgoTherapeutix Press Mentions
Stay in the know about the latest news on AlgoTherapeutix
Topical pharmaceutical composition in the form of aqueous gel comprising at …
patents • Apr 02, 2025
Topical pharmaceutical composition comprising amitriptyline and an alkaline …
patents • Apr 02, 2025
AlgoTx Announces Results of its Phase 2 “ACT” Trial of ATX01 in Chemotherapy-Induced Peripheral Neuropathy
morningstar • Feb 18, 2025
French biotech’s topical pain treatment fails Phase 2 study with overperforming placebo
endpts • Feb 18, 2025
AlgoTx Announces Results of its Phase 2 “ACT” Trial of ATX01 in Chemotherapy-Induced Peripheral Neuropathy
globenewswire • Feb 18, 2025
AlgoTherapeutix Management
Leadership team at AlgoTherapeutix
Co-Founder
Olivier Bohuon
Co-Founder, Chief Executive Officer & President
Stéphane Thiroloix
Join now and verify your accreditation status to gain access to:
- AlgoTherapeutix Current Valuation
- AlgoTherapeutix Stock Price
- AlgoTherapeutix Management
- Available deals in AlgoTherapeutix and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- AlgoTherapeutix Cap Table and Funding History by Share Class and Liquidity Preferences
- AlgoTherapeutix Revenue and Financials
- AlgoTherapeutix Highlights
- AlgoTherapeutix Business Model
- AlgoTherapeutix Risk Factors
- AlgoTherapeutix Research Report from SACRA Research
Trading AlgoTherapeutix Stock
How to invest in AlgoTherapeutix stock?
Accredited investors can buy pre-IPO stock in companies like AlgoTherapeutix through EquityZen funds. These investments are made available by existing AlgoTherapeutix shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell AlgoTherapeutix stock?
Shareholders can sell their AlgoTherapeutix stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
